menu
    • menu

    Company profile for SciSparc

    NEW Drugs in Dev: 10
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. Our focus is on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the Company is currently engaged in the following drug development programs based on THC and/or non-psychoactive cannabidiol (CBD): SCI-110 (formerly THX-110) for the...
    SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. Our focus is on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the Company is currently engaged in the following drug development programs based on THC and/or non-psychoactive cannabidiol (CBD): SCI-110 (formerly THX-110) for the treatment of Tourette syndrome and for the treatment of obstructive sleep apnea; SCI-160 (formerly THX-160) for the treatment of pain

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SciSparcIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    20 Raul Wallenberg Street, Tower A Tel Aviv
    Telephone
    Telephone
    972-3-616-7055
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://scisparc.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    SciSparc Inks Patent Deal for Multi-Billion Endoscope Market
    SciSparc Inks Patent Deal for Multi-Billion Endoscope Market

    13 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/13/3217619/0/en/SciSparc-Signs-Definitive-Agreement-to-Acquire-a-Treasury-of-Patents-for-the-Endoscope-Market-Entering-Multi-Billion-Dollar-Opportunity.html

    GLOBENEWSWIRE
    13 Jan 2026
    Share Share
    Scisparc Notified Of Nasdaq Stockholders' Equity Non-Compliance
    Scisparc Notified Of Nasdaq Stockholders' Equity Non-Compliance

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3217342/0/en/SciSparc-Announces-Receipt-of-Nasdaq-Notification-of-Minimum-Stockholders-Equity-Non-Compliance.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    SciSparc's Neurothera Secures Israeli Patent for Safer Opioids
    SciSparc's Neurothera Secures Israeli Patent for Safer Opioids

    30 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/30/3211377/0/en/SciSparc-Neurothera-Labs-Granted-Patent-by-Israeli-Patent-Office-for-its-Proprietary-Opioid-Based-Patent-Family-to-Enhance-Pain-Relief-and-Reduce-Side-Effects.html

    GLOBENEWSWIRE
    30 Dec 2025
    Share Share
    Neurothera Labs To Acquire Majority Stake In Quantum Algorithm
    Neurothera Labs To Acquire Majority Stake In Quantum Algorithm

    02 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/02/3198102/0/en/SciSparc-Neurothera-Labs-Signs-Non-Binding-Term-Sheet-to-Acquire-Majority-Stake-in-a-Quantum-Algorithm-Bio-Data-Analysis-Company.html

    GLOBENEWSWIRE
    02 Dec 2025
    Share Share
    Scisparc Acquires Xylo Technologies' Endoscopic Portfolio
    Scisparc Acquires Xylo Technologies' Endoscopic Portfolio

    01 Dec 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/scisparc-acquires-xylo-technologies-innovative-endoscopic-portfolio-18413

    INDPHARMAPOST
    01 Dec 2025
    Share Share
    Scisparc Acquires Patents For Innovative Medical Endoscopy System
    Scisparc Acquires Patents For Innovative Medical Endoscopy System

    26 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/26/3195068/0/en/SciSparc-to-Acquire-Treasury-of-Patents-for-Innovative-Medical-Endoscopy-Systems.html

    GLOBENEWSWIRE
    26 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search